The current role of MRI in differentiating multiple sclerosis from its imaging mimics

SPECIAL REPORT

Multiple Sclerosis

Vaccination Readiness in Multiple Sclerosis

Multiple Sclerosis

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

Lancet Neurol

Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, Fazekas F, Filippi M, Frederiksen J, Gasperini C, Hacohen Y, Kappos L, Li DKB, Mankad K, Montalban X, Newsome SD, Oh J, Palace J, Rocca MA, Sastre-Garriga J, Tintoré M, Traboulsee A, Vrenken H, Yousry T, Barkhof F, Rovira À, Magnetic Resonance Imaging in Multiple Sclerosis study group., Consortium of Multiple Sclerosis Centres., North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group.

doi: 10.1016/S1474-4422(21)00095-8

Multiple Sclerosis

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

J Neuroinflammation.

Nakamura Y, Gaetano L, Matsushita T, Anna A, Sprenger T, Radue EW, Wuerfel J, Bauer L, Amann M, Shinoda K, Isobe N, Yamasaki R, Saida T, Kappos L, Kira JI

doi: 10.1186/s12974-018-1295-1.

Multiple Sclerosis

The role of the cerebellum in multiple sclerosis-150 years after Charcot

Neurosci Biobehav Rev.

Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T

doi: 10.1016/

Multiple Sclerosis

Differentiating Enhancing Multiple Sclerosis Lesions, Glioblastoma, and Lymphoma with Dynamic Texture Parameters Analysis (DTPA) - a Feasibility Study

Med Phys.

Verma RK, Wiest R, Locher C, Heldner MR, Schucht P, Raabe A, Gralla J, Kamm CP, Slotboom J, Kellner-Weldon F

doi: 10.1002/mp.12356.

Multiple Sclerosis

Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies

Ann Neurol.

Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G, Spagni G, Barilaro A, Repice AM, Emmi L, Prisco D, Martinelli V, Scotti R, Sadeghi N, Perrotta G, Sati P, Dachy B, Reich DS, Filippi M, Massacesi L

doi: 10.1002/ana.25146.

Multiple Sclerosis

Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

JAMA Neurol.

Regev K, Healy BC, Khalid F, Paul A, Chu R, Tauhid S, Tummala S, Diaz-Cruz C, Raheja R, Mazzola MA, von Glehn F, Kivisakk P, Dupuy SL, Kim G, Chitnis T, Weiner HL, Gandhi R, Bakshi R

doi: 10.1001/

SPECIAL REPORT

Multiple Sclerosis

Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis

RECOMMENDED

Aging and Cognitive FunctionsMultiple Sclerosis

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis

Brain.

Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O

doi: 10.1093/brain/awz156.

Related content

Vaccination Readiness in Multiple Sclerosis

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

The role of the cerebellum in multiple sclerosis-150 years after Charcot

Differentiating Enhancing Multiple Sclerosis Lesions, Glioblastoma, and Lymphoma with Dynamic Texture Parameters Analysis (DTPA) - a Feasibility Study

Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies

Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis